Benign prostatic hyperplasia (BPH) is a common urological condition in aging males, leading to lower urinary tract symptoms (LUTS) that significantly affect quality of life. Alpha-adrenergic blockers are the first-line pharmacological treatment for BPH. This study evaluates and compares the efficacy, tolerability, and side-effect profiles of three commonly used alpha-blockers: tamsulosin, alfuzosin, and silodosin. Our analysis reveals important differences in patient outcomes and provides guidance for individualized therapy.

Benign prostatic hyperplasia, alpha-blockers, tamsulosin, silodosin, LUTS, urology

Oelke, M., et al. (2013). EAU Guidelines on the Management of Non-Neurogenic Male LUTS, including BPH. European Urology, 64(1), 118–140.

Roehrborn, C. G. (2008). Benign prostatic hyperplasia: An overview. Reviews in Urology, 10(Suppl 1), S3–S10.

Lepor, H. (2007). Alpha-blockers for the treatment of benign prostatic hyperplasia. Reviews in Urology, 9(4), 181–190.

Файзуллаев, Т., & Хужамбердиева, Ш. (2020). ЭРКИН ВОҲИДОВ ИЖОДИНИ УМУМИЙ ЎРТА ТАЪЛИМ МАКТАБЛАРИДА ЎРГАНИШДА ЁШЛАРНИ ВАТАПАРВАРЛИК РУҲИДА ТАРБИЯЛАШНИНГ АҲАМИЯТИ. Scientific Bulletin of Namangan State University, 2(4), 543-546.

Boymirzayeva, S. (2025). DIDACTIC FORMS AND METHODS OF PEDAGOGICAL SUPPORT AND TARGETED DEVELOPMENT OF CHILDREN IN THE PROCESS OF PRESCHOOL EDUCATION. Journal of Multidisciplinary Sciences and Innovations, 1(1), 557-562.

Turdaliyeva, N., & Mamadjonova, D. (2024). MAKTABGACHA TA’LIM TASHKILOTLARIDA BOLALARGA TA’LIM-TARBIYA BERISHDA IJODIY O’YINLARDAN FOYDALANISH. Nordic_Press, 5(0005).

Mukhamedova, M., & Arnopolskaya, D. (2013). The Nitric Oxide System in Patients with Chronic Heart Failure. International Journal of Biomedicine, 3(3), 180-183.

Юллиев, Н. Ж., Сафарова, Д. Д., Мусаева, У. А., & Нурбаев, Б. Ш. (2015). Особенности физической подготовки спасателей МЧС с учетом условий среднегорья. Наука и спорт: современные тенденции, 8(3), 47-53.

Khujamberdieva, S. (2023). SPECIFIC TASKS OF INTRODUCING CHILDREN TO LITERARY WORKS. Collection of scientific papers «SCIENTIA», (May 5, 2023; Sydney, Australia), 145-147.

Chung, B. H. (2010). The role of silodosin in the treatment of BPH. Therapeutic Advances in Urology, 2(4), 157–164.

McConnell, J. D., et al. (2003). The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of BPH. The New England Journal of Medicine, 349, 2387–2398.